CSI Laboratories

Summary

A cyberattack targeted Cytometry Specialists (CSI Laboratories), compromising sensitive patient information including names, birth dates, medical records, and insurance details. The laboratory confirmed the incident and assured affected individuals that their data was unlikely to have been further misused, while implementing enhanced security measures to prevent future breaches. This event reflects a broader trend of threat actors increasingly focusing on specialized healthcare entities beyond traditional hospital systems.

Motives

Detailed motive labels are available to members.

TTPs

Detailed technique labels are available to members.

Description

In February 2022, Cytometry Specialists, operating as CSI Laboratories, experienced a cyberattack compromising sensitive patient information. The breach exposed personally identifiable information and protected health data, including patient names, dates of birth, medical records, and insurance details. The incident occurred on or around February 12, 2022, though the exact duration of unauthorized system access remains unspecified in public disclosures. As a cancer testing laboratory specializing in diagnostic services, the compromise impacted individuals whose specimens were analyzed by the facility. CSI Laboratories confirmed the breach through internal investigations but did not publicly identify whether ransomware, hacking, or another attack vector caused the intrusion. The organization notified affected patients about the exposure of their clinical and insurance information but stated no evidence suggested further misuse of the compromised data.

Following the breach, CSI Laboratories implemented security improvements to prevent recurrence, though specific technical measures were not detailed in their public statements. The incident highlighted broader cybersecurity challenges facing specialized healthcare laboratories, as third-party vendors and niche providers increasingly became targets according to industry analyses published contemporaneously. Operational disruptions were not explicitly reported, but the disclosure process adhered to federal health data breach notification requirements. The laboratory maintained continuity of clinical services throughout the incident response period while coordinating with forensic experts to assess the attack's scope. No ransomware payments or data theft claims by threat actors were documented in relation to this event. Patient outreach emphasized vigilance against potential identity theft despite the organization's assessment of low risk for additional data exploitation.

Sources

Sources available to members: 1 source.